Literature DB >> 4019570

Cloning ovarian carcinoma cells in an agar double layer versus a methylcellulose monolayer system. A comparison of two methods.

H M Runge, H A Neumann, W Bücke, A Pfleiderer.   

Abstract

Human ovarian cancer cells from ten patients were cultured in the agar double layer assay as described by Hamburger and Salmon and in a methylcellulose monolayer system. The assays were compared under the same experimental conditions. The rate of positives (defined as greater than 30 colonies/dish) was 75% in the methylcellulose assay and 69% in the agar double layer. Plating efficiency ranged in the methylcellulose assay between 0.021% and 0.089% and in the agar double layer from 0.015% to 0.094%. Cytological and cytochemical staining of cells obtained from colonies in both test systems and of the tumour cells prior to plating revealed the same morphology. The methylcellulose monolayer system requires less additives than necessary in the agar double layer system. Furthermore, it is easier to handle with respect to the plating procedure and less time consuming. In addition, the effect of the anti-oestrogen tamoxifen on colony formation was tested. The dose response curves for colony formation with tamoxifen proved to be identical in both systems. At a concentration of 10(-6) M an inhibition of colony formation of more than 70% of controls was observed in the agar and in the methylcellulose system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019570     DOI: 10.1007/bf00402502

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE.

Authors:  L S KAPLOW
Journal:  Blood       Date:  1965-08       Impact factor: 22.113

2.  Rosette formation by peripheral lymphocytes.

Authors:  P Brain; J Gordon; W A Willetts
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

3.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

4.  Human marrow erythropoiesis in culture. I. Characterization of methylcellulose colony assay.

Authors:  M Ogawa; R T Parmley; H L Bank; S S Spicer
Journal:  Blood       Date:  1976-09       Impact factor: 22.113

5.  Advanced ovarian carcinoma: response to antiestrogen therapy.

Authors:  A M Myers; G E Moore; F J Major
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

6.  Correlation of tumor-cell growth in four semisolid systems.

Authors:  Z P Pavelic; N J Nowak; H K Slocum; Y M Rustum
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

7.  Tamoxifen therapy for advanced ovarian cancer.

Authors:  P E Schwartz; G Keating; N MacLusky; F Naftolin; A Eisenfeld
Journal:  Obstet Gynecol       Date:  1982-05       Impact factor: 7.661

8.  Tumor colony formation from human spontaneous tumors in a methylcellulose monolayer system.

Authors:  H A Neumann; G W Löhr; A A Fauser
Journal:  Res Exp Med (Berl)       Date:  1984

9.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Authors:  S E Salmon; A W Hamburger; B Soehnlen; B G Durie; D S Alberts; T E Moon
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

10.  Growth of human tumour cell colonies from biopsies using two soft-agar techniques.

Authors:  V D Courtenay; P J Selby; I E Smith; J Mills; M J Peckham
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

View more
  2 in total

1.  Comparison of in vivo and in vitro activity of estrogen-linked nitrosoureas in methylnitrosourea-induced rat mammary carcinoma.

Authors:  E Petru; M R Berger; M Kaufmann
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Cytotoxic activity of the thioether phospholipid analogue BM 41.440 in primary human tumor cultures.

Authors:  D B Herrmann; H A Neumann
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.